Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. and Schreiber, R.D. (2001) IFNg and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410, 1107-1111.doi10.1038/35074122 - References

Journals by Subject

Publish with us

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. and Schreiber, R.D. (2001) IFNg and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410, 1107-1111. doi:10.1038/35074122

has been cited by the following article:

TITLE: New era in cancer immunotherapy: Twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors

AUTHORS: Britta Hardy, Annat Raiter

KEYWORDS: Cancer Immunotherapy; Monoclonal Antibodies; Anergy; T Cell Receptors

JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.4A, April 29, 2013

ABSTRACT: The better understanding of the mechanism in which the immune system responds to the developing cancer provided the outcome in a new era in cancer immunotherapy. The tumor suppressive effect on the immune system is caused by negative T cell receptor signaling that abrogate immunity against the cancer cells. Novel monoclonal antibodies that target co-inhibitory receptors on T cells block the tumor induced inhibition of the immune system and enable the immune system to eradicate the tumors. The development of such antibodies started twenty years ago by the preparation of a monoclonal antibody termed BAT. A single administration of the antibody to tumor bearing mice resulted in striking anti tumor activity that was mediated by the lymphocytes. These studies provided a basis for the new era of cancer immunotherapy. The present review summarizes twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors.

Open Access

Articles

Prediction of Response to Neoadjuvant Chemotherapy in Egyptian Patients with Locally Advanced Breast Cancer: The Evolving Role of Tumour Infiltrating Lymphocytes (TILs)

Manal M. El-Mahdy, Riham A. Ibrahim, Radwa M. Hamed, Mohamaad S. Elkady, Walid A. Bayoumy, Zeinab M. Elsayed, Mai M. Ezz-El-Din

Journal of Cancer Therapy Vol.11 No.4, April 22, 2020

DOI: 10.4236/jct.2020.114018
Open Access

Articles

Presentation of Pott’s Puffy Tumour in a 71-Year-Old Man with Atypical History

Sapna Shivdas, Andrew Beynon Philips

Open Access Library Journal Vol.9 No.6, June 22, 2022

DOI: 10.4236/oalib.1108734
Open Access

Articles

Primary Small Bowel Tumour Presenting as Bowel Obstruction in a Patient with a Virgin Abdomen

Xilin Wu, Hester Y. S. Cheung, Cliff C. C. Chung, Michael K. W. Li

International Journal of Clinical Medicine Vol.2 No.5, November 28, 2011

DOI: 10.4236/ijcm.2011.25108
Open Access

Articles

Primary Small Bowel Tumour Presenting as Bowel Obstruction in a Patient with a Virgin Abdomen

Xilin Wu, Hester Y. S. Cheung, Cliff C. C. Chung, Michael K. W. Li

International Journal of Clinical Medicine Vol.4 No.6, June 17, 2013

DOI: 10.4236/ijcm.2013.46050
Open Access

Articles

Peripheral Primary Neuroectodermal Tumour of the Ileum: A Case Report and Review of the Literature

Soukaina Harrak, Siham Lemsanes, Sawsan Razine, Salma Najem, Khadija Benchekroun, Saad Lannaz, Hind Mrabti, Hassan Errihani

Journal of Cancer Therapy Vol.12 No.7, July 8, 2021

DOI: 10.4236/jct.2021.127035

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies